Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cangrelor in Comatose Survivors of Out-of-hospital Cardiac Arrest Undergoing Primary PCI
NCT04005729Phase 4Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jul 2019
- Primary completion
- Nov 2021
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of cangrelor in cardiac arrest (SCA), acute coronary syndrome (ACS), sponsored by University Medical Centre Ljubljana. Started Jul 2019; status: completed.
02
Drugs
cangrelor
03
Conditions
cardiac arrest (SCA)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04005729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04005729.